CPSE:DEMANT 수익, 비용 및 수입 (DKK Millions )
날짜	수익	수익	G+A 비용	R&D 비용
31 Dec 23	22,443	2,552	11,036	1,410
30 Sep 23	21,903	2,464	10,937	1,390
30 Jun 23	21,363	2,375	10,838	1,369
31 Mar 23	20,534	2,325	10,542	1,342
31 Dec 22	19,705	2,274	10,246	1,314
30 Sep 22	19,181	2,460	9,851	1,274
30 Jun 22	18,656	2,645	9,455	1,233
31 Mar 22	18,281	2,671	9,178	1,186
31 Dec 21	17,905	2,696	8,900	1,139
30 Sep 21	17,521	2,453	8,651	1,170
30 Jun 21	17,137	2,209	8,401	1,200
31 Mar 21	15,803	1,665	8,145	1,231
31 Dec 20	14,469	1,121	7,889	1,261
30 Sep 20	14,072	970	7,952	1,224
30 Jun 20	13,674	818	8,014	1,186
31 Mar 20	14,310	1,140	8,138	1,153
31 Dec 19	14,946	1,462	8,261	1,120
30 Sep 19	14,728	1,579	8,068	1,093
30 Jun 19	14,510	1,695	7,874	1,066
31 Mar 19	14,224	1,759	7,593	1,030
31 Dec 18	13,937	1,823	7,312	994
30 Sep 18	13,699	1,836	7,084	956
30 Jun 18	13,461	1,849	6,856	918
31 Mar 18	13,325	1,802	6,809	887
31 Dec 17	13,189	1,754	6,762	856
30 Sep 17	12,943	1,689	6,680	831
30 Jun 17	12,697	1,624	6,597	806
31 Mar 17	12,350	1,542	6,436	795
31 Dec 16	12,002	1,459	6,275	784
30 Sep 16	11,717	1,429	6,068	787
30 Jun 16	11,432	1,399	5,860	790
31 Mar 16	11,049	1,418	5,573	777
31 Dec 15	10,665	1,436	5,285	763
30 Sep 15	10,258	1,402	5,090	731
30 Jun 15	9,850	1,367	4,894	699
31 Mar 15	9,598	1,347	4,693	690
31 Dec 14	9,346	1,326	4,491	680
30 Sep 14	9,221	1,301	4,420	673
30 Jun 14	9,095	1,275	4,348	665
31 Mar 14	9,027	1,280	4,294	650
31 Dec 13	8,959	1,285	4,239	634
30 Sep 13	8,830	1,235	4,098	645

양질의 수익: DEMANT 은 높은 수익을 보유하고 있습니다.

이익 마진 증가: DEMANT 의 현재 순이익 이익률 (11.4%) 작년보다 낮습니다 (11.5%).

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: DEMANT 의 수입은 지난 5년 동안 매년 13.8% 씩 증가했습니다.

성장 가속화: 지난 1년간 DEMANT 의 수익 증가율( 12.2% )은 5년 평균( 13.8% 보다 낮습니다. 년도).

수익 대 산업: 지난 1년간 DEMANT 수익 증가율( 12.2% )은 Medical Equipment 업계 4.9% 초과했습니다.

자기자본 수익률

높은 ROE: DEMANT 의 자본 수익률( 27.36% )이 높음이지만, 이 지표는 높은 부채 수준으로 인해 왜곡됩니다.

Demant 과거 수익 실적

과거 기준 확인 3/6

주요 정보

최근 과거 실적 업데이트

Full year 2023 earnings: EPS misses analyst expectations

Demant A/S to Report Nine Months, 2024 Results on Nov 04, 2024

First half 2023 earnings released: EPS: kr.5.63 (vs kr.5.07 in 1H 2022)

Full year 2022 earnings: EPS misses analyst expectations

Demant A/S to Report Fiscal Year 2022 Results on Feb 07, 2023

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Recent updates

Here's Why We Think Demant (CPH:DEMANT) Might Deserve Your Attention Today

At kr.326, Is It Time To Put Demant A/S (CPH:DEMANT) On Your Watch List?

Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 97% Above Its Share Price

We Think Demant (CPH:DEMANT) Can Stay On Top Of Its Debt

Cochlear Limited (ASX:COH) acquired Oticon Medical A/s from Demant A/S (CPSE:DEMANT).

Demant A/S Provides Earnings Guidance for the Year 2024

Investors Still Waiting For A Pull Back In Demant A/S (CPH:DEMANT)

Now 20% undervalued

Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?

Capital Allocation Trends At Demant (CPH:DEMANT) Aren't Ideal

Here's Why We Think Demant (CPH:DEMANT) Is Well Worth Watching

Demant (CPH:DEMANT) Has A Pretty Healthy Balance Sheet

Full year 2023 earnings: EPS misses analyst expectations

Anja Madsen Announces Not to Stand for Re-Election to the Board of Directors of Demant A/S

Demant A/S (CPH:DEMANT) Not Flying Under The Radar

A Look At The Fair Value Of Demant A/S (CPH:DEMANT)

At kr.302, Is Demant A/S (CPH:DEMANT) Worth Looking At Closely?

Demant A/S to Report Nine Months, 2024 Results on Nov 04, 2024

Now 21% undervalued after recent price drop

Demant A/S Provides Earnings Guidance for the Year 2023

Some Investors May Be Worried About Demant's (CPH:DEMANT) Returns On Capital

Is Demant (CPH:DEMANT) Using Too Much Debt?

Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 34% Above Its Share Price

Now 21% undervalued

Price target increased by 7.4% to kr.286

First half 2023 earnings released: EPS: kr.5.63 (vs kr.5.07 in 1H 2022)

Here's What's Concerning About Demant's (CPH:DEMANT) Returns On Capital

Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?

Now 21% undervalued

A Look At The Fair Value Of Demant A/S (CPH:DEMANT)

Demant A/S Announces Executive Changes

Here's Why Demant (CPH:DEMANT) Can Manage Its Debt Responsibly

Now 21% undervalued

Investor sentiment improves as stock rises 16%

Demant (CPH:DEMANT) May Have Issues Allocating Its Capital

Is It Too Late To Consider Buying Demant A/S (CPH:DEMANT)?

Now 20% undervalued

Are Investors Undervaluing Demant A/S (CPH:DEMANT) By 25%?

These 4 Measures Indicate That Demant (CPH:DEMANT) Is Using Debt Reasonably Well

Full year 2022 earnings: EPS misses analyst expectations

Investor sentiment improves as stock rises 16%

Demant A/S to Report Fiscal Year 2022 Results on Feb 07, 2023

Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 77% Above Its Share Price

Capital Investments At Demant (CPH:DEMANT) Point To A Promising Future

Less than half of directors are independent

Price target decreased to kr.230

Demant A/S Revised Earnings Guidance for the Full Year of 2022

Price target decreased to kr.264

We Think Demant (CPH:DEMANT) Can Stay On Top Of Its Debt

Does Demant (CPH:DEMANT) Deserve A Spot On Your Watchlist?

Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 95% Above Its Share Price

What Is Demant A/S's (CPH:DEMANT) Share Price Doing?

Demant A/S Revises Earnings Guidance for the Full Year 2022

Many Would Be Envious Of Demant's (CPH:DEMANT) Excellent Returns On Capital

Demant (CPH:DEMANT) Seems To Use Debt Rather Sparingly

Investor sentiment deteriorated over the past week

Demant A/S (CPSE:DEMANT) acquired remaining 80% interest in ShengWang for CNY.

Demant A/S (CPH:DEMANT) Shares Could Be 42% Below Their Intrinsic Value Estimate

If You Like EPS Growth Then Check Out Demant (CPH:DEMANT) Before It's Too Late

Is Now The Time To Look At Buying Demant A/S (CPH:DEMANT)?

Less than half of directors are independent

Now 20% undervalued after recent price drop

Shareholders Are Optimistic That Demant (CPH:DEMANT) Will Multiply In Value

Is Demant (CPH:DEMANT) A Risky Investment?

Demant A/S Appoints Niels Wagner to the Board of Directors

Shareholders Would Not Be Objecting To Demant A/S' (CPH:DEMANT) CEO Compensation And Here's Why

Is There An Opportunity With Demant A/S' (CPH:DEMANT) 23% Undervaluation?

Should You Be Adding Demant (CPH:DEMANT) To Your Watchlist Today?

Full year 2021 earnings: Revenues and EPS in line with analyst expectations